Ушбу иш иқтибос қилган ишлар

201 та иш

Иш: Targeted Protein Degradation and Delivery Strategies in the Context of Neurological Disorders

Polymeric Nanoparticles for Drug Delivery
Maximilian A. Beach, Umeka Nayanathara, Yanting Gao +4
Шарҳ мақола20247 иқтибос
ABI
Engineering precision nanoparticles for drug delivery
Michael J. Mitchell, Margaret M. Billingsley, Rebecca M. Haley +3
Шарҳ мақола20205 иқтибос
ABI
mTOR: a pharmacologic target for autophagy regulation
Young Chul Kim, Kun‐Liang Guan
Шарҳ мақола20154 иқтибос
ABI
Extracellular vesicles as a next-generation drug delivery platform
Inge K. Herrmann, Matthew J. A. Wood, Gregor Fuhrmann
Шарҳ мақола20214 иқтибос
ABI
Preparation of pegylated nano-liposomal formulation containing SN-38: In vitro characterization and in vivo biodistribution in mice
Fatemeh Atyabi, Anahita Farkhondehfai, Farnaz Esmaeili +1
Мақола20093 иқтибос
ABI
Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease
Evandro Fei Fang, Yujun Hou, Konstantinos Palikaras +17
Мақола20193 иқтибос
ABI
Cell-Penetrating Peptides (CPPs) as Therapeutic and Diagnostic Agents for Cancer
Ryan A. Bottens, Tohru Yamada
Шарҳ мақола20223 иқтибос
ABI
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Lei Zhong, Yueshan Li, Liang Xiong +8
Шарҳ мақола20213 иқтибос
ABI
Targeted protein degradation via the autophagy-lysosome system: AUTOTAC (AUTOphagy-TArgeting Chimera)
Chang Hoon Ji, Min Ju Lee, Hee Yeon Kim +5
Бошқа20223 иқтибос
ABI
Targeted Protein Degradation in Cancer: PROTACs, New Targets, and Clinical Mechanisms
Bushra Faryal, Zain Ul Abideen, Muhammad Irfan +4
МақолаProtein Degradation and InhibitorsBiomolecules20262 иқтибос
ABI
Advances of Stimuli-Responsive Amphiphilic Copolymer Micelles in Tumor Therapy
Yao Wang, Meng Lin, Tianfei Fan +3
Шарҳ мақола20242 иқтибос
ABI
Supramolecular artificial Nano-AUTACs enable tumor-specific metabolism protein degradation for synergistic immunotherapy
Yazhen Wang, Lianyi Yang, C. Yan +8
Мақола20242 иқтибос
ABI
ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner
Huai-Xiang Hao, Yang Xie, Yue Zhang +16
Мақола20122 иқтибос
ABI
Advanced drug delivery systems: Nanotechnology of health design A review
Javad Safari, Zohre Zarnegar
Шарҳ мақола20132 иқтибос
ABI
Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery
Bethany Almeida, Okhil K. Nag, Katherine E. Rogers +1
Шарҳ мақола20202 иқтибос
ABI
Protac-Induced Protein Degradation in Drug Discovery: Breaking the Rules or Just Making New Ones?
Ian Churcher
Шарҳ мақола20172 иқтибос
ABI
AUTACs: Cargo-Specific Degraders Using Selective Autophagy
Daiki Takahashi, Jun Moriyama, Tomoe Y. Nakamura +6
Мақола20192 иқтибос
ABI
Targeting estrogen receptor α for degradation with PROTACs: A promising approach to overcome endocrine resistance
Xin Lin, Hua Xiang, Guoshun Luo
Шарҳ мақола20202 иқтибос
ABI
Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1
Adam D. Cotton, Duy Nguyen, Josef A. Gramespacher +2
Мақола20212 иқтибос
ABI
Covalently Engineered Nanobody Chimeras for Targeted Membrane Protein Degradation
Heng Zhang, Yu Han, Yuanfan Yang +7
Мақола20212 иқтибос
ABI
PROTAC targeted protein degraders: the past is prologue
Miklós Békés, David R. Langley, Craig M. Crews
Шарҳ мақола20222 иқтибос
ABI
Proteolysis-targeting chimeras (PROTACs) in cancer therapy
Xinyi Li, Wenchen Pu, Qingquan Zheng +3
Мақола20222 иқтибос
ABI
Molecular Glues: Capable Protein-Binding Small Molecules That Can Change Protein–Protein Interactions and Interactomes for the Potential Treatment of Human Cancer and Neurodegenerative Diseases
Fengzhi Li, Ieman Aljahdali, Xiang Ling
Шарҳ мақола20222 иқтибос
ABI
Targeted Protein Degradation via Lysosomes
Rishi R. Paudel, Dong Lu, Sandipan Chowdhury +2
Шарҳ мақола20222 иқтибос
ABI
Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
Jihoon Lee, Ki Woon Sung, Eun-Jin Bae +12
Мақола20232 иқтибос
ABI